IRADIMED CORPORATION Announces Retirement of Brent Johnson and the Appointment of MaryBeth Smith as Vice President of Worldwide Sales

About this update from Iradimed Corporation

[{"type":"text","content":"WINTER SPRINGS, Fla., Jan. 07, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Brent Johnson, Executive Vice President of Worldwide Sales and Marketing, effective April 10, 2020 after leading the Company’s commercial efforts since 2012. IRADIMED appointed MaryBeth Smith as Vice President of Worldwide Sales, succeeding Mr. Johnson, effective January 20, 2020. Ms. Smith will report to Leslie McDonnell, President and Chief Executive Officer.\n “Under Brent’s leadership, IRADIMED achieved compound annual sales growth of 26% by significantly expanding its U.S. sales force and international distributor network and entering new markets. We would like to congratulate Brent on his retirement and thank him for his many contributions and commitment to a successful transition,” said McDonnell. “MaryBeth has a strong track record of delivering sales growth, customer retention and market expansion. I am confident MaryBeth will do a fantastic job of building upon our past success and helping lead the Company into the future. We are excited to add her to the executive team,” said McDonnell. About MaryBeth Smith Ms. Smith has extensive commercial experience with medical technology products. Prior to her appointment at IRADIMED, Ms. Smith spent more than 20 years at Natus Medical, Inc., most recently as the Vice President of Sales and Sales Operations for newborn care products. Prior to that, Ms. Smith held a number of leadership and operational roles at Natus where she successfully introduced and established new products as a standard of care. Ms. Smith earned a Bachelor of Science in Nursing from Viterbo University. About IRADIMED CORPORATION IRADIMED CORPORATION is a leader in the development of innovative magnetic resonance imaging (“MRI”) compatible medical devices. We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system that is specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium® MRI compa...

More updates from Iradimed Corporation